Megan Elizabeth Bowles Clowse, MD

Associate Professor of Medicine
Campus mail Baker House 07, Duke South, Trent Drive, Durham, NC 27710
Phone (919) 681-2045
Email address megan.clowse@duke.edu

Dr. Megan Clowse is an Associate Professor of Medicine, Rheumatology and Immunology.  Her clinical research focuses on the management of rheumatologic diseases in pregnancy. She has cared for over 600 pregnancies in women with rheumatic diseases, collecting information on these pregnancies initially in the Duke Autoimmunity in Pregnancy Registry and Repository, and now the Maternal Autoimmune Disease Research Alliance registry and repository.  She served on the Core Leadership Team for the inaugural American College of Rheumatology's Reproductive Health Guidelines, due in 2019.  Dr. Clowse has created www.LupusPregnancy.org, a website dedicated to improving lupus pregnancy planning and management for patients and rheumatologists.  

Dr. Clowse was the founding director of the Duke Lupus Clinic, where she continues to see patients each week and mentor junior faculty researchers.  The team has developed a new approach to lupus classification and management and is currently collecting and analyzing patient- and physician-reported measures to  better clarify this construct.  

As a Clinical Associate Director of Duke Forge, Dr. Clowse is shepherding several Department of Medicine funded pilot studies to identify and build innovative approaches to using health data to improve patient care. 

In Their Words

Education and Training

  • Fellow in Rheumatology, Medicine, Johns Hopkins University, 2002 - 2005
  • Medical Residetn, Medicine, Johns Hopkins University, 1999 - 2002
  • M.D., Vanderbilt University, 1999
  • M.P.H., University of California at Los Angeles, 1994

Publications

Balevic, SJ, Green, TP, Clowse, MEB, Eudy, AM, Schanberg, LE, and Cohen-Wolkowiez, M. "Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases." Clinical Pharmacokinetics 58, no. 4 (April 2019): 525-533.

PMID
30255310
Full Text

Leverenz, DL, Eudy, AM, Jayasundara, M, Haroun, T, McDaniel, G, Benjamin Nowell, W, Curtis, JR, Crow-Hercher, R, White, W, Ginsberg, S, and Clowse, MEB. "Contraception methods used by women with rheumatoid arthritis and psoriatic arthritis.(Accepted)" Clinical Rheumatology 38, no. 4 (April 2019): 1207-1212.

PMID
30649682
Full Text

Harris, N, Eudy, A, and Clowse, M. "Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis." March 2019.

PMID
29908013
Full Text

Clowse, MEB. "It Is Time to Modify Treatment to Enable More Women with Rheumatoid Arthritis to Have Successful Pregnancies." The Journal of Rheumatology 46, no. 3 (March 2019): 223-225.

PMID
30824666
Full Text

Eudy, AM, McDaniel, G, and Clowse, MEB. "Pregnancy outcomes, fertility, and family planning in women with psoriatic arthritis." Obstetric Medicine (January 1, 2019).

Full Text

Eudy, AM, Siega-Riz, AM, Engel, SM, Franceschini, N, Howard, AG, Clowse, MEB, and Petri, M. "Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus." The Journal of Rheumatology 46, no. 1 (January 2019): 70-77.

PMID
30008449
Full Text

Balevic, SJ, Cohen-Wolkowiez, M, Eudy, AM, Green, TP, Schanberg, LE, and Clowse, MEB. "Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes." The Journal of Rheumatology 46, no. 1 (January 2019): 57-63.

PMID
30275257
Full Text

Clowse, MEB, Eudy, AM, Revels, J, Neil, L, and Sanders, GD. "Provider perceptions on the management of lupus during pregnancy: barriers to improved care." Lupus 28, no. 1 (January 2019): 86-93.

PMID
30522398
Full Text

Clowse, ME, Eudy, AM, Revels, J, Sanders, GD, and Criscione-Schreiber, L. "Rheumatologists' knowledge of contraception, teratogens, and pregnancy risks." Obstet Med 11, no. 4 (December 2018): 182-185.

PMID
30574180
Full Text

Kimball, AB, Clowse, MEB, Scheuerle, AE, Chambers, C, Afzali, A, Cush, JJ, Cooney, M, Shauhnessy, L, Vanderkelen, M, and Forger, F. "Characteristics and outcomes of pregnancies exposed to certolizumab pegol prospectively reported to a safety database." Annual Meeting of the American-Academy-of-Dermatology (AAD). San Diego, CA. February 16, 2018 - February 20, 2018.: MOSBY-ELSEVIER, September 1, 2018.

Scholars@Duke

Pages